Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFN-02 Safety Study in Acute Migraine
NCT02279082Phase 3Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Sep 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sumatriptan in migraine, sponsored by Dr. Reddy's Laboratories. Started Sep 2014; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02279082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279082.